Hemostatic properties of in situ gels composed of hydrophobically modified biopolymers
- 10 August 2018
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 33 (2) , 315-323
Abstract
Hemorrhaging often occurs during cardiac surgery, and postoperative bleeding is associated with medical complications or even death. Medical complications resulting from hemorrhaging can lead to longer hospital stays, thus increasing costs. Hemostatic agents are the main treatment for bleeding. In the present study, hemostatic agents composed of aldehyde groups and hydrophobically modified with hyaluronic acid (ald-hm-HyA) and hydrophobically modified gelatin (hm-ApGltn) were developed and their hemostatic effects were evaluated. These modified hemostatic agents formed more stable blood clots compared with the nonhydrophobically modified HyA-based hemostatic agent. The bulk strength of the whole blood clot using the aldehyde and stearoyl group-modified hyaluronic acid (ald-C18-HyA)/hm-ApGltn-based hemostatic agent was higher than that of the aldehyde group only modified HyA (ald-HyA)/hm-ApGltn-based hemostatic agent. Rheological experiments using α-cyclodextrin showed that hydrophobic modification of HyA with C18 groups effectively enhanced anchoring to the red blood cell surface. Therefore, the ald-hm-HyA/hm-ApGltn-based hemostatic agent has potential applications in cardiac surgery.Keywords
This publication has 43 references indexed in Scilit:
- Development of a Biostable Replacement for PEGDA HydrogelsBiomacromolecules, 2012
- Topical hemostatic agents in surgical practiceTransfusion and Apheresis Science, 2011
- A self-assembling hydrophobically modified chitosan capable of reversible hemostatic actionBiomaterials, 2011
- Enhanced insulin secretion of physically crosslinked pancreatic β-cells by using a poly(ethylene glycol) derivative with oleyl groupsActa Biomaterialia, 2009
- Topical Hemostatic Agents in Surgery: A Surgeon's PerspectiveAORN Journal, 2008
- Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cellsProceedings of the National Academy of Sciences, 2007
- Efficient Synthesis of an Aldehyde Functionalized Hyaluronic Acid and Its Application in the Preparation of Hyaluronan−Lipid ConjugatesBioconjugate Chemistry, 2006
- Controlled clinical trial of a novel hemostatic agent in cardiac surgeryThe Annals of Thoracic Surgery, 2000
- Biocompatibility and performance in vitro of a hemostatic gelatin spongeJournal of Biomaterials Science, Polymer Edition, 2000
- Mechanical Measurement of Red Cell Membrane ThicknessScience, 1983